ZA200509132B - N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors - Google Patents
N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitorsInfo
- Publication number
- ZA200509132B ZA200509132B ZA200509132A ZA200509132A ZA200509132B ZA 200509132 B ZA200509132 B ZA 200509132B ZA 200509132 A ZA200509132 A ZA 200509132A ZA 200509132 A ZA200509132 A ZA 200509132A ZA 200509132 B ZA200509132 B ZA 200509132B
- Authority
- ZA
- South Africa
- Prior art keywords
- noradrenaline
- serotonin
- pyrrolidin
- amide derivatives
- uptake inhibitors
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
- 239000003112 inhibitor Substances 0.000 title 1
- 230000000966 norepinephrine reuptake Effects 0.000 title 1
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical class NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 title 1
- 229940076279 serotonin Drugs 0.000 title 1
- 230000000697 serotonin reuptake Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314048.0A GB0314048D0 (en) | 2003-06-17 | 2003-06-17 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200509132B true ZA200509132B (en) | 2007-02-28 |
Family
ID=27636730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200509132A ZA200509132B (en) | 2003-06-17 | 2005-11-11 | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN1835921A (xx) |
| GB (1) | GB0314048D0 (xx) |
| GT (1) | GT200400121A (xx) |
| NO (1) | NO20060190L (xx) |
| OA (1) | OA13178A (xx) |
| RS (1) | RS20050924A (xx) |
| TN (1) | TNSN05321A1 (xx) |
| UA (1) | UA80338C2 (xx) |
| ZA (1) | ZA200509132B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2010129690A (ru) * | 2007-12-19 | 2012-01-27 | Дайниппон Сумитомо Фарма Ко., Лтд. (Jp) | Бициклические гетероциклические производные |
-
2003
- 2003-06-17 GB GBGB0314048.0A patent/GB0314048D0/en not_active Ceased
-
2004
- 2004-06-07 RS YUP-2005/0924A patent/RS20050924A/sr unknown
- 2004-06-07 OA OA1200500363A patent/OA13178A/en unknown
- 2004-06-07 CN CNA2004800172229A patent/CN1835921A/zh active Pending
- 2004-06-15 GT GT200400121A patent/GT200400121A/es unknown
- 2004-07-06 UA UAA200511011A patent/UA80338C2/uk unknown
-
2005
- 2005-11-11 ZA ZA200509132A patent/ZA200509132B/xx unknown
- 2005-12-16 TN TNP2005000321A patent/TNSN05321A1/fr unknown
-
2006
- 2006-01-12 NO NO20060190A patent/NO20060190L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RS20050924A (sr) | 2008-04-04 |
| TNSN05321A1 (fr) | 2007-07-10 |
| NO20060190L (no) | 2006-01-12 |
| UA80338C2 (en) | 2007-09-10 |
| CN1835921A (zh) | 2006-09-20 |
| OA13178A (en) | 2006-12-13 |
| GT200400121A (es) | 2005-03-03 |
| GB0314048D0 (en) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL172063A0 (en) | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
| AP2048A (en) | Diazepinoindole derivatives as kinase inhibitors | |
| IL173381A0 (en) | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors | |
| PL364580A1 (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
| SI1492785T1 (sl) | 2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3 | |
| IS8806A (is) | Fenýl-píperidín afleiður sem serótónín endurupptökuhindrar | |
| AU2003271566A8 (en) | Pyrrolopyrazines as kinase inhibitors | |
| IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
| AU2003288444A1 (en) | Methods and compositions for preventing fracture proppant flowback | |
| IL172132A0 (en) | Thienopyridone derivatives as kinase inhibitors | |
| GB0325192D0 (en) | Method of use | |
| PL1789041T3 (pl) | Pochodne arylopirydyny jako inhibitory 11-beta-HSD1 | |
| GB0314054D0 (en) | Amide derivatives as selective serotonin re-uptake inhibitors | |
| SI1797042T1 (sl) | Indozolonski derivati kot inhibitorji 11b-hsd1 | |
| IL169323A0 (en) | Pyrazole-derivatives as factor xa inhibitors | |
| EP1667989A4 (en) | SUBSTITUTED ISOQUINOLEINONES | |
| IL154343A0 (en) | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors | |
| EP1670739A4 (en) | CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS | |
| PL374581A1 (en) | Diaminothiazoles and use thereof as cdk4 inhibitors | |
| IL173521A0 (en) | Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists | |
| IL173904A0 (en) | Combinations comprising alpha-2-delta ligands and serotonin/noradrenaline re-uptake inhibitors | |
| IL172542A0 (en) | 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide | |
| PL373533A1 (en) | Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors | |
| IL176772A0 (en) | Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors | |
| ZA200508151B (en) | Benzimidazole-derivatives as factor Xa inhibitors |